semaglutide tirzepatide conversion & Dosing Guide: mg to Units Chart Switching between weight-loss medications -

In clinical studies, people treated with GLP-1 receptor agonists were much more likely to lose at least 5% of their body weight than those who did not receive the medication

In the years since, the market has expanded with new players, including Eli Lillys tirzepatide-based Zepbound for weight loss and Mounjaro for diabetes

Participants were randomized to receive either Tirzepatide (5, 10, 15, 20, or 30 mg) or semaglutide (1 mg) once a week for 40 weeks

Clinical trials show tirzepatide alone produces weight loss of 20 to 35 pounds over 68 weeks, with greater losses at higher doses

These benefits go beyond weight reduction and contribute to overall long-term health improvement

Similar content being viewed by others Introduction Obesity and the associated type 2 diabetes are major contributors to global morbidity and mortality, are increasingly prevalent, and require prompt treatment [1]